amiodarone: be used in fibrillation

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents drug
Weight: 0.58
, medicine
Weight: 0.54
, agent
Weight: 0.45
, medication
Weight: 0.45
Siblings warfarin
Weight: 0.36
, vancomycin
Weight: 0.35
, acetaminophen
Weight: 0.35
, ibuprofen
Weight: 0.34
, metronidazole
Weight: 0.34

Related properties

Property Similarity
be used in fibrillation 1.00
be used in atrial fibrillation 0.92
be contraindicated in cardiogenic shock 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.03
Rule weight: 0.13
Evidence weight: 0.25
Similarity weight: 0.92
Evidence: 0.90
¬ Remarkable(amiodarone, be used in fibrillation)
Evidence: 0.83
¬ Remarkable(warfarin, be used in atrial fibrillation)
0.03
Rule weight: 0.13
Evidence weight: 0.20
Similarity weight: 1.00
Evidence: 0.90
¬ Remarkable(amiodarone, be used in fibrillation)
Evidence: 0.89
¬ Remarkable(warfarin, be used in fibrillation)

Remarkability from sibling implausibility

0.58
Rule weight: 0.60
Evidence weight: 0.96
Similarity weight: 1.00
Evidence: 0.28
Plausible(amiodarone, be used in fibrillation)
Evidence: 0.89
Remarkable(warfarin, be used in fibrillation)
Evidence: 0.47
¬ Plausible(warfarin, be used in fibrillation)
0.51
Rule weight: 0.60
Evidence weight: 0.93
Similarity weight: 0.92
Evidence: 0.28
Plausible(amiodarone, be used in fibrillation)
Evidence: 0.83
Remarkable(warfarin, be used in atrial fibrillation)
Evidence: 0.58
¬ Plausible(warfarin, be used in atrial fibrillation)

Salient implies Plausible

0.18
Rule weight: 0.28
Evidence weight: 0.65
Similarity weight: 1.00
Evidence: 0.28
Plausible(amiodarone, be used in fibrillation)
Evidence: 0.48
¬ Salient(amiodarone, be used in fibrillation)

Similarity expansion

0.72
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.92
Evidence: 0.90
Remarkable(amiodarone, be used in fibrillation)
Evidence: 0.82
¬ Remarkable(amiodarone, be used in atrial fibrillation)
0.62
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.92
Evidence: 0.09
Typical(amiodarone, be used in fibrillation)
Evidence: 0.24
¬ Typical(amiodarone, be used in atrial fibrillation)
0.60
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.75
Evidence: 0.90
Remarkable(amiodarone, be used in fibrillation)
Evidence: 0.67
¬ Remarkable(amiodarone, be contraindicated in cardiogenic shock)
0.58
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.92
Evidence: 0.28
Plausible(amiodarone, be used in fibrillation)
Evidence: 0.37
¬ Plausible(amiodarone, be used in atrial fibrillation)
0.57
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.92
Evidence: 0.48
Salient(amiodarone, be used in fibrillation)
Evidence: 0.52
¬ Salient(amiodarone, be used in atrial fibrillation)
0.46
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.75
Evidence: 0.48
Salient(amiodarone, be used in fibrillation)
Evidence: 0.56
¬ Salient(amiodarone, be contraindicated in cardiogenic shock)
0.43
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.75
Evidence: 0.28
Plausible(amiodarone, be used in fibrillation)
Evidence: 0.47
¬ Plausible(amiodarone, be contraindicated in cardiogenic shock)
0.37
Rule weight: 0.85
Evidence weight: 0.58
Similarity weight: 0.75
Evidence: 0.09
Typical(amiodarone, be used in fibrillation)
Evidence: 0.46
¬ Typical(amiodarone, be contraindicated in cardiogenic shock)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.96
Similarity weight: 1.00
Evidence: 0.48
Salient(amiodarone, be used in fibrillation)
Evidence: 0.09
¬ Typical(amiodarone, be used in fibrillation)
Evidence: 0.90
¬ Remarkable(amiodarone, be used in fibrillation)

Typical implies Plausible

0.45
Rule weight: 0.48
Evidence weight: 0.94
Similarity weight: 1.00
Evidence: 0.28
Plausible(amiodarone, be used in fibrillation)
Evidence: 0.09
¬ Typical(amiodarone, be used in fibrillation)

Typicality and Rermarkability incompatibility between siblings

0.10
Rule weight: 0.14
Evidence weight: 0.74
Similarity weight: 1.00
Evidence: 0.90
¬ Remarkable(amiodarone, be used in fibrillation)
Evidence: 0.29
¬ Typical(warfarin, be used in fibrillation)
0.07
Rule weight: 0.14
Evidence weight: 0.56
Similarity weight: 0.92
Evidence: 0.90
¬ Remarkable(amiodarone, be used in fibrillation)
Evidence: 0.49
¬ Typical(warfarin, be used in atrial fibrillation)